Endpoint definition
↥Filter registries None
Check pre-conditions None
Include endpoints
Check conditions None
Apply sex-specific rule None
Extra metadata
Filter registries None
Check pre-conditions None
Include endpoints
Check conditions None
Apply sex-specific rule None
Extra metadata
List of similar endpoints to ILD Co-morbidites, CVD and metabolic diseases based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
All | Female | Male | |
---|---|---|---|
Number of individuals | 98348 | 45353 | 52995 |
Unadjusted prevalence (%) | 37.82 | 30.86 | 46.87 |
Mean age at first event (years) | 56.29 | 55.60 | 56.88 |
Follow-up | Absolute risk | HR [95% CI] | p | N |
---|---|---|---|---|
1998–2019 | 0.05 | 5.31 [4.96, 5.68] | <1e-100 | 16861 |
15 years | 0.03 | 6.62 [6.19, 7.08] | <1e-100 | 13919 |
5 years | 0.01 | 10.96 [10.01, 12.00] | <1e-100 | 6174 |
1 year | 0.00 | 26.02 [21.79, 31.06] | <1e-100 | 2843 |
Index endpoint: ILD_CVDMETABOCOMORB – ILD Co-morbidites, CVD and metabolic diseases
GWS hits:
before ILD Co-morbidites, CVD and metabolic diseases
after ILD Co-morbidites, CVD and metabolic diseases
Loading survival analyses plot
Loading survival analyses table